Forecast: Pharmaceutical Industry Exports in Finland

The value of pharmaceutical industry exports in Finland was $1.27 billion USD in 2023. Over the years, from 2013 to 2023, this industry has demonstrated significant volatility. The most prominent declines were noted in 2015 with an 18.72% drop and in 2019 with a 14.18% decrease. However, noteworthy rebounds occurred in 2020 with a 27.56% increase, followed by a robust climb in 2021 at 30.11%. The recent period up to 2023, shows modest yet steady growth with year-on-year variations of 1.66% in 2022 and 1.81% in 2023.

Looking forward, the industry is projected to continue its gradual upward trajectory, advancing from $1.29 billion USD in 2024 to $1.38 billion USD in 2028. The forecasted compound annual growth rate (CAGR) for the next five years is 1.3%, suggesting a moderate increase in export values.

Future trends to watch for:

• Potential impacts of global healthcare reforms and policies affecting export regulations.
• Advancements in pharmaceutical technology and biotechnology that could drive export demand.
• Shifts in global market dynamics, including competition and emerging markets, influencing Finland's export landscape.